Centocor to make ID's methicillin-resistant Staphylococcus aureus (MRSA) culture test:
This article was originally published in Clinica
Centocor has agreed to manufacture ID Biomedical's rapid culture test kit for methicillin-resistant Staphylococcus aureus (MRSA). The kits will be used in clinical trials which it is hoped will lead to an application for US marketing approval. A recent trial of the kit correctly identified MRSA in all but one of 451 samples tested.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.